Friday March 19 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Lymphocytic News and Headlines
Lymphocytic News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Lymphocytic news alerts.
Site Map > Biotechnology News > Health News > Lymphocytic
.

Assessment of Peripheral Blood and Bone Marrow Cells Apoptosis Caused by Purine Analogues in Patients with Chronic Lymphocytic Leukemia in Correlation with Parameters of Disease Progression
Acta Haematologica:  similar ...
Medical News: NICE Set To Recommend Rituximab For Relapsed Or Refractory Chronic Lymphocytic Leukaemia
BioFind:  similar ...
NICE Set To Recommend Rituximab For Relapsed Or Refractory Chronic Lymphocytic Leukaemia
Medical News Today:  similar ...
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia [Hematolo
Journal of Clinical Oncology:  similar ...
Rituxan Approved for Chronic Lymphocytic Leukemia
Cancer Consultants:  similar ...
FDA Approves Rituxan for Chronic Lymphocytic Leukemia
BioPharm International:  similar ...
FDA Expands Use Of Rituxan For Chronic Lymphocytic Leukemia (DJ)
Easy Bourse:  similar ...
FDA Approves Rituxan Plus Chemotherapy for the Most Common Type of Adult Leukemia
PharmiWeb:  similar ...
Rituxan Approved for Chronic Lymphocytic Leukemia
Modern Medicine:  similar ...
FDA Approves Rituxan Plus Chemotherapy for the Most Common Type of Adult Leukemia
Pharma Live:  similar ...
Rituxan Approved for Chronic Lymphocytic Leukemia
National Womens Health Information Center:  similar ...
FDA Approves Rituximab for Chronic Lymphocytic Leukemia
Medscape:  similar ...
FDA Approves Rituximab for Chronic Lymphocytic Leukemia
Abstracts in Hematology and Oncology:  similar ...
Medical News: FDA Approves Rituxan To Treat Chronic Lymphocytic Leukemia
BioFind:  similar ...
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Pharma Live:  similar ...
FDA Approves Rituximab to Treat Chronic Lymphocytic Leukaemia
Doctors Guide:  similar ...
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Pharmacy Choice:  similar ...
FDA Approves Rituximab to Treat Chronic Lymphocytic Leukaemia
PSL Group:  similar ...
2/18/10 - FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Pharmacy Choice:  similar ...
Rituxan anti-cancer drug receives FDA approval
News-Medical.Net:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.